More normal business drives the performance
30/10/24 -"Nivea and Eucerin posted robust growth in the Q3, driven by innovation and strong demand in emerging markets. This is expected to result in increased profitability in the H2, although it will be ..."
Pages
55
Language
English
Published on
30/10/24
You may also be interested by these reports :
15/09/26
Puig has agreed to acquire the remaining 50% stake in ISDIN for €1.2bn, taking full ownership of the dermocosmetics brand. The group will pay €900m ...
14/09/26
Since its July 2022 listing, Haleon (BUY; UK) has delivered a total return of just under 20%. Unexciting, but not for want of progress. Assembled ...
08/09/26
Bic’s 2030 strategy is credible and modestly positive for earnings and cash flow, with c.3% organic growth and >15.5% EBIT margin targets above the ...
08/09/26
BIC’s new 2030 strategy looks positive for earnings and cash generation, with growth, margin and capex targets ahead of the current consensus. The ...